JP2014516087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516087A5 JP2014516087A5 JP2014514933A JP2014514933A JP2014516087A5 JP 2014516087 A5 JP2014516087 A5 JP 2014516087A5 JP 2014514933 A JP2014514933 A JP 2014514933A JP 2014514933 A JP2014514933 A JP 2014514933A JP 2014516087 A5 JP2014516087 A5 JP 2014516087A5
- Authority
- JP
- Japan
- Prior art keywords
- tocopherol
- formulation
- butanol
- pentanol
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161495672P | 2011-06-10 | 2011-06-10 | |
| US61/495,672 | 2011-06-10 | ||
| PCT/US2012/041950 WO2013036309A2 (en) | 2011-06-10 | 2012-06-11 | Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516087A JP2014516087A (ja) | 2014-07-07 |
| JP2014516087A5 true JP2014516087A5 (enExample) | 2017-07-27 |
| JP6339011B2 JP6339011B2 (ja) | 2018-06-06 |
Family
ID=47832748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514933A Active JP6339011B2 (ja) | 2011-06-10 | 2012-06-11 | 眼へのタンパク質の送出のための持続放出性製剤及びその調製方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9814773B2 (enExample) |
| EP (1) | EP2717914B1 (enExample) |
| JP (1) | JP6339011B2 (enExample) |
| KR (1) | KR20140060274A (enExample) |
| CN (1) | CN103945865B (enExample) |
| AU (1) | AU2012304909B2 (enExample) |
| BR (1) | BR112013031685B1 (enExample) |
| CA (1) | CA2838289C (enExample) |
| CY (1) | CY1122771T1 (enExample) |
| DK (1) | DK2717914T3 (enExample) |
| ES (1) | ES2761340T3 (enExample) |
| HR (1) | HRP20192276T1 (enExample) |
| HU (1) | HUE047737T2 (enExample) |
| IN (1) | IN2013MN02384A (enExample) |
| LT (1) | LT2717914T (enExample) |
| MX (1) | MX359119B (enExample) |
| PL (1) | PL2717914T3 (enExample) |
| PT (1) | PT2717914T (enExample) |
| RS (1) | RS60051B1 (enExample) |
| SI (1) | SI2717914T1 (enExample) |
| SM (1) | SMT202000021T1 (enExample) |
| WO (1) | WO2013036309A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6530744B2 (ja) * | 2013-05-24 | 2019-06-12 | アイコン バイオサイエンス インコーポレイテッド | 白内障手術後の炎症における徐放性デキサメタゾンの使用 |
| KR102312186B1 (ko) * | 2014-05-08 | 2021-10-14 | 판옵테스 파르마 게스.엠.베.하. | 안 질환 및 장애 치료용 화합물 |
| ES2969514T3 (es) * | 2015-03-18 | 2024-05-21 | Santen Pharmaceutical Co Ltd | Composición farmacéutica de liberación sostenida |
| CA2991015A1 (en) * | 2015-07-01 | 2017-01-05 | Santen Pharmaceutical Co., Ltd. | Depot preparation containing citric acid ester |
| WO2017024027A1 (en) * | 2015-08-03 | 2017-02-09 | Tolmar International Limited | Liquid polymer delivery system for extended administration of drugs |
| PT3352735T (pt) | 2015-09-21 | 2023-10-30 | Teva Pharmaceuticals Int Gmbh | Formulações de olanzapina de libertação sustentada |
| AU2018238136A1 (en) | 2017-03-20 | 2019-11-07 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulations |
| KR101957599B1 (ko) | 2017-10-23 | 2019-03-13 | 김상현 | 훈제 단무지 제조 방법, 이에 의해 제조된 훈제 단무지 |
| WO2019157198A2 (en) | 2018-02-09 | 2019-08-15 | Icon Bioscience, Inc. | Systems, kits and methods for loading and delivering a small volume dose from a syringe |
| EP3787609A4 (en) | 2018-05-01 | 2022-01-05 | Chibi, Inc. | Eye drop formulation and method for sustained delivery of medicament to the retina |
| KR20210003877A (ko) | 2018-05-01 | 2021-01-12 | 치비 인코포레이티드 | 약제를 눈에 비침습적으로 지속 전달하기 위한 액체 데포 |
| EP4153214A4 (en) | 2020-05-22 | 2024-06-26 | Trustees of Boston University | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASE |
| EP4277661A1 (en) | 2021-01-18 | 2023-11-22 | Anton Frenkel | Pharmaceutical dosage form |
| US20240277654A1 (en) | 2021-07-06 | 2024-08-22 | Mark Hasleton | Treatment of serotonin reuptake inhibitor withdrawal syndrome |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658432B1 (fr) * | 1990-02-22 | 1994-07-01 | Medgenix Group Sa | Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation. |
| EP1299048A4 (en) * | 2000-06-28 | 2005-09-28 | Atul J Shukla | BIODEGRADABLE VEHICLES AND SYSTEMS FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES |
| TWI353854B (en) * | 2002-06-25 | 2011-12-11 | Alza Corp | Short duration depot formulations |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| CA2527664A1 (en) * | 2003-05-30 | 2004-12-16 | Alza Corporation | Implantable elastomeric depot compositions, uses thereof and method of manufacturing |
| US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| US7771742B2 (en) * | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| US8685435B2 (en) * | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
| WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| BRPI0516830A (pt) * | 2004-10-01 | 2008-09-23 | Ramscor Inc | composições de droga de liberação sustentada convenientemente implantáveis |
| BRPI0516308A2 (pt) * | 2004-10-04 | 2010-06-15 | Qlt Usa Inc | composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida |
| US8039010B2 (en) | 2006-11-03 | 2011-10-18 | Allergan, Inc. | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
| US8821870B2 (en) * | 2008-07-18 | 2014-09-02 | Allergan, Inc. | Method for treating atrophic age related macular degeneration |
| WO2010105093A2 (en) * | 2009-03-12 | 2010-09-16 | Delpor, Inc. | Implantable device for long-term delivery of drugs |
| EP2269663B1 (en) * | 2009-07-03 | 2018-03-07 | Armbruster Biotechnology GmbH | Bone graft and biocomposite |
-
2012
- 2012-06-11 IN IN2384MUN2013 patent/IN2013MN02384A/en unknown
- 2012-06-11 ES ES12829655T patent/ES2761340T3/es active Active
- 2012-06-11 JP JP2014514933A patent/JP6339011B2/ja active Active
- 2012-06-11 MX MX2013014461A patent/MX359119B/es active IP Right Grant
- 2012-06-11 LT LTEP12829655.5T patent/LT2717914T/lt unknown
- 2012-06-11 SM SM20200021T patent/SMT202000021T1/it unknown
- 2012-06-11 BR BR112013031685-3A patent/BR112013031685B1/pt active IP Right Grant
- 2012-06-11 WO PCT/US2012/041950 patent/WO2013036309A2/en not_active Ceased
- 2012-06-11 PT PT128296555T patent/PT2717914T/pt unknown
- 2012-06-11 RS RS20191574A patent/RS60051B1/sr unknown
- 2012-06-11 SI SI201231706T patent/SI2717914T1/sl unknown
- 2012-06-11 HU HUE12829655A patent/HUE047737T2/hu unknown
- 2012-06-11 EP EP12829655.5A patent/EP2717914B1/en active Active
- 2012-06-11 US US14/124,631 patent/US9814773B2/en active Active
- 2012-06-11 HR HRP20192276TT patent/HRP20192276T1/hr unknown
- 2012-06-11 DK DK12829655.5T patent/DK2717914T3/da active
- 2012-06-11 PL PL12829655T patent/PL2717914T3/pl unknown
- 2012-06-11 CA CA2838289A patent/CA2838289C/en active Active
- 2012-06-11 CN CN201280028816.4A patent/CN103945865B/zh active Active
- 2012-06-11 AU AU2012304909A patent/AU2012304909B2/en active Active
- 2012-06-11 KR KR1020147000443A patent/KR20140060274A/ko not_active Withdrawn
-
2020
- 2020-01-17 CY CY20201100042T patent/CY1122771T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516087A5 (enExample) | ||
| KR101341359B1 (ko) | 편리하게 이식가능한 서방형 약물 조성물 | |
| JP6416154B2 (ja) | 眼房内ビマトプロスト注入物による眼圧低下 | |
| US9011915B2 (en) | Conveniently implantable sustained release drug compositions | |
| Heller | Ocular delivery using poly (ortho esters) | |
| CN107184544A (zh) | 前房内持续释放治疗药植入物 | |
| JP6339011B2 (ja) | 眼へのタンパク質の送出のための持続放出性製剤及びその調製方法 | |
| CA2993340C (en) | Intravitreal drug delivery systems for the treatment of ocular conditions | |
| KR20160100992A (ko) | 눈의 병태의 치료를 위한 전방내 이식물 | |
| CN109602691A (zh) | 持续药物递送植入物 | |
| WO2015135306A1 (zh) | 青蒿素及其衍生物在制备防治眼科血管性疾病药物中的应用及药物组合物 | |
| Einmahl et al. | Ocular biocompatibility of a poly (ortho ester) characterized by autocatalyzed degradation | |
| KR102191180B1 (ko) | 안질환 치료용 조성물 | |
| KR102183669B1 (ko) | 이중 약물 방출을 위한 약물 전달체 | |
| Augustin et al. | Suprachoroidal drug delivery–a new approach for the treatment of severe macular diseases | |
| CN102406627B (zh) | 一种层层组装马赛克结构药物缓释植片 | |
| CN105496947A (zh) | 一种药物缓释制剂 | |
| CN1846700A (zh) | 5－氟尿嘧啶玻璃体腔缓释系统 | |
| HK1107672B (en) | Conveniently implantable sustained release drug compositions |